You just read:

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

News provided by

ReportBuyer

Sep 14, 2016, 16:57 ET